Gain-of-function mutations in the catalytic domain of <i>DOT1L</i> promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
Lihui Wang(Genedata (Switzerland))
Cited by 22
Related Papers
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
|Cell Death and Disease|2017|134
Inactivation of <i>SMAD4</i> Tumor Suppressor Gene During Gastric Carcinoma Progression
|Clinical Cancer Research|2007|111
An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
|Molecular Cancer|2022|62
<p>LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis</p>
|OncoTargets and Therapy|2019|25